 | • レポートコード：D005-01005 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、治療薬モニタリングの世界市場を広く調査・分析し、今後の市場展望をまとめております。治療薬モニタリングの種類別市場規模（抗てんかん薬、抗不整脈薬、免疫抑制薬、抗生物質薬、気管支拡張薬、精神活性薬、その他）、用途別市場規模（商業・民間研究室、病院研究室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Buhlmann Laboratories、Thermo Fisher、Roche、Biomerieux、Siemens Healthineers、Randox Laboratories、Bio-Rad Laboratories、Danaher、Sekisui Medical ・地域別グローバル市場分析 2015年-2020年 ・治療薬モニタリングの北米市場（アメリカ、カナダ、メキシコ） ・治療薬モニタリングのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・治療薬モニタリングのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・治療薬モニタリングの南米市場（ブラジル、アルゼンチン） ・治療薬モニタリングの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗てんかん薬、抗不整脈薬、免疫抑制薬、抗生物質薬、気管支拡張薬、精神活性薬、その他 ・用途別分析：商業・民間研究室、病院研究室、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Therapeutic Drug Monitoring market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1227.9 million by 2025, from USD 1082.5 million in 2019.
The Therapeutic Drug Monitoring market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Therapeutic Drug Monitoring market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Therapeutic Drug Monitoring market has been segmented into:
Antiepileptic Drugs
Antiarrhythmic Drugs
Immunosuppressant Drugs
Antibiotic Drugs
Bronchodilator Drugs
Psychoactive Drugs
Other Drug Classes
By Application, Therapeutic Drug Monitoring has been segmented into:
Commercial/Private Labs
Hospital Labs
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Therapeutic Drug Monitoring market presented in the report. This section sheds light on the sales growth of different regional and country-level Therapeutic Drug Monitoring markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Therapeutic Drug Monitoring market.
The report offers in-depth assessment of the growth and other aspects of the Therapeutic Drug Monitoring market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Therapeutic Drug Monitoring Market Share Analysis
Therapeutic Drug Monitoring competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Therapeutic Drug Monitoring sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Therapeutic Drug Monitoring sales, revenue and market share for each player covered in this report.
The major players covered in Therapeutic Drug Monitoring are:
Abbott Laboratories
Buhlmann Laboratories
Thermo Fisher
Roche
Biomerieux
Siemens Healthineers
Randox Laboratories
Bio-Rad Laboratories
Danaher
Sekisui Medical
Table of Contents
1 Therapeutic Drug Monitoring Market Overview
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Classification of Therapeutic Drug Monitoring by Type
1.2.1 Global Therapeutic Drug Monitoring Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Therapeutic Drug Monitoring Revenue Market Share by Type in 2019
1.2.3 Antiepileptic Drugs
1.2.4 Antiarrhythmic Drugs
1.2.5 Immunosuppressant Drugs
1.2.6 Antibiotic Drugs
1.2.7 Bronchodilator Drugs
1.2.8 Psychoactive Drugs
1.2.9 Other Drug Classes
1.3 Global Therapeutic Drug Monitoring Market by Application
1.3.1 Overview: Global Therapeutic Drug Monitoring Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Commercial/Private Labs
1.3.3 Hospital Labs
1.3.4 Others
1.4 Global Therapeutic Drug Monitoring Market by Regions
1.4.1 Global Therapeutic Drug Monitoring Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Therapeutic Drug Monitoring (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Therapeutic Drug Monitoring Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Therapeutic Drug Monitoring Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Therapeutic Drug Monitoring Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Therapeutic Drug Monitoring Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Therapeutic Drug Monitoring Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.2 Buhlmann Laboratories
2.2.1 Buhlmann Laboratories Details
2.2.2 Buhlmann Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Buhlmann Laboratories SWOT Analysis
2.2.4 Buhlmann Laboratories Product and Services
2.2.5 Buhlmann Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.3 Thermo Fisher
2.3.1 Thermo Fisher Details
2.3.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Thermo Fisher SWOT Analysis
2.3.4 Thermo Fisher Product and Services
2.3.5 Thermo Fisher Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biomerieux
2.5.1 Biomerieux Details
2.5.2 Biomerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biomerieux SWOT Analysis
2.5.4 Biomerieux Product and Services
2.5.5 Biomerieux Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens Healthineers
2.6.1 Siemens Healthineers Details
2.6.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens Healthineers SWOT Analysis
2.6.4 Siemens Healthineers Product and Services
2.6.5 Siemens Healthineers Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.7 Randox Laboratories
2.7.1 Randox Laboratories Details
2.7.2 Randox Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Randox Laboratories SWOT Analysis
2.7.4 Randox Laboratories Product and Services
2.7.5 Randox Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio-Rad Laboratories SWOT Analysis
2.8.4 Bio-Rad Laboratories Product and Services
2.8.5 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.9 Danaher
2.9.1 Danaher Details
2.9.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Danaher SWOT Analysis
2.9.4 Danaher Product and Services
2.9.5 Danaher Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sekisui Medical
2.10.1 Sekisui Medical Details
2.10.2 Sekisui Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sekisui Medical SWOT Analysis
2.10.4 Sekisui Medical Product and Services
2.10.5 Sekisui Medical Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Therapeutic Drug Monitoring Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Therapeutic Drug Monitoring Players Market Share
3.2.2 Top 10 Therapeutic Drug Monitoring Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Therapeutic Drug Monitoring Revenue and Market Share by Regions
4.2 North America Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
4.3 Europe Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
4.5 South America Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
5 North America Therapeutic Drug Monitoring Revenue by Countries
5.1 North America Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
5.2 USA Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
5.3 Canada Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
5.4 Mexico Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
6 Europe Therapeutic Drug Monitoring Revenue by Countries
6.1 Europe Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
6.2 Germany Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
6.3 UK Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
6.4 France Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
6.5 Russia Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
6.6 Italy Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Therapeutic Drug Monitoring Revenue by Countries
7.1 Asia-Pacific Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
7.2 China Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
7.3 Japan Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
7.4 Korea Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
7.5 India Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
8 South America Therapeutic Drug Monitoring Revenue by Countries
8.1 South America Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
8.2 Brazil Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
8.3 Argentina Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Therapeutic Drug Monitoring by Countries
9.1 Middle East & Africa Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
9.2 Saudi Arabia Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
9.3 UAE Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
9.4 Egypt Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
9.5 South Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Therapeutic Drug Monitoring Revenue and Market Share by Type (2015-2020)
10.2 Global Therapeutic Drug Monitoring Market Forecast by Type (2019-2024)
10.3 Antiepileptic Drugs Revenue Growth Rate (2015-2025)
10.4 Antiarrhythmic Drugs Revenue Growth Rate (2015-2025)
10.5 Immunosuppressant Drugs Revenue Growth Rate (2015-2025)
10.6 Antibiotic Drugs Revenue Growth Rate (2015-2025)
10.7 Bronchodilator Drugs Revenue Growth Rate (2015-2025)
10.8 Psychoactive Drugs Revenue Growth Rate (2015-2025)
10.9 Other Drug Classes Revenue Growth Rate (2015-2025)
11 Global Therapeutic Drug Monitoring Market Segment by Application
11.1 Global Therapeutic Drug Monitoring Revenue Market Share by Application (2015-2020)
11.2 Therapeutic Drug Monitoring Market Forecast by Application (2019-2024)
11.3 Commercial/Private Labs Revenue Growth (2015-2020)
11.4 Hospital Labs Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Therapeutic Drug Monitoring Market Size Forecast (2021-2025)
12.1 Global Therapeutic Drug Monitoring Market Size Forecast (2021-2025)
12.2 Global Therapeutic Drug Monitoring Market Forecast by Regions (2021-2025)
12.3 North America Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
12.4 Europe Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
12.6 South America Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Therapeutic Drug Monitoring Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Therapeutic Drug Monitoring Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Therapeutic Drug Monitoring Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Therapeutic Drug Monitoring Major Business
Table 7. Abbott Laboratories Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 10. Abbott Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Buhlmann Laboratories Corporate Information, Location and Competitors
Table 12. Buhlmann Laboratories Therapeutic Drug Monitoring Major Business
Table 13. Buhlmann Laboratories Therapeutic Drug Monitoring Total Revenue (USD Million) (2018-2019)
Table 14. Buhlmann Laboratories SWOT Analysis
Table 15. Buhlmann Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 16. Buhlmann Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Thermo Fisher Corporate Information, Location and Competitors
Table 18. Thermo Fisher Therapeutic Drug Monitoring Major Business
Table 19. Thermo Fisher Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 20. Thermo Fisher SWOT Analysis
Table 21. Thermo Fisher Therapeutic Drug Monitoring Product and Solutions
Table 22. Thermo Fisher Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Therapeutic Drug Monitoring Major Business
Table 25. Roche Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Therapeutic Drug Monitoring Product and Solutions
Table 28. Roche Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Biomerieux Corporate Information, Location and Competitors
Table 30. Biomerieux Therapeutic Drug Monitoring Major Business
Table 31. Biomerieux Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 32. Biomerieux SWOT Analysis
Table 33. Biomerieux Therapeutic Drug Monitoring Product and Solutions
Table 34. Biomerieux Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Siemens Healthineers Corporate Information, Location and Competitors
Table 36. Siemens Healthineers Therapeutic Drug Monitoring Major Business
Table 37. Siemens Healthineers Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 38. Siemens Healthineers SWOT Analysis
Table 39. Siemens Healthineers Therapeutic Drug Monitoring Product and Solutions
Table 40. Siemens Healthineers Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Randox Laboratories Corporate Information, Location and Competitors
Table 42. Randox Laboratories Therapeutic Drug Monitoring Major Business
Table 43. Randox Laboratories Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 44. Randox Laboratories SWOT Analysis
Table 45. Randox Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 46. Randox Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 48. Bio-Rad Laboratories Therapeutic Drug Monitoring Major Business
Table 49. Bio-Rad Laboratories Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 50. Bio-Rad Laboratories SWOT Analysis
Table 51. Bio-Rad Laboratories Therapeutic Drug Monitoring Product and Solutions
Table 52. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Danaher Corporate Information, Location and Competitors
Table 54. Danaher Therapeutic Drug Monitoring Major Business
Table 55. Danaher Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 56. Danaher SWOT Analysis
Table 57. Danaher Therapeutic Drug Monitoring Product and Solutions
Table 58. Danaher Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sekisui Medical Corporate Information, Location and Competitors
Table 60. Sekisui Medical Therapeutic Drug Monitoring Major Business
Table 61. Sekisui Medical Therapeutic Drug Monitoring Total Revenue (USD Million) (2017-2018)
Table 62. Sekisui Medical SWOT Analysis
Table 63. Sekisui Medical Therapeutic Drug Monitoring Product and Solutions
Table 64. Sekisui Medical Therapeutic Drug Monitoring Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Therapeutic Drug Monitoring Revenue (Million USD) by Players (2015-2020)
Table 66. Global Therapeutic Drug Monitoring Revenue Share by Players (2015-2020)
Table 67. Global Therapeutic Drug Monitoring Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Therapeutic Drug Monitoring Revenue Market Share by Regions (2015-2020)
Table 69. North America Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
Table 70. North America Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Table 71. Europe Therapeutic Drug Monitoring Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Therapeutic Drug Monitoring Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Therapeutic Drug Monitoring Revenue by Countries (2015-2020)
Table 74. South America Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Therapeutic Drug Monitoring Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Table 77. Global Therapeutic Drug Monitoring Revenue (Million USD) by Type (2015-2020)
Table 78. Global Therapeutic Drug Monitoring Revenue Share by Type (2015-2020)
Table 79. Global Therapeutic Drug Monitoring Revenue Forecast by Type (2021-2025)
Table 80. Global Therapeutic Drug Monitoring Revenue by Application (2015-2020)
Table 81. Global Therapeutic Drug Monitoring Revenue Share by Application (2015-2020)
Table 82. Global Therapeutic Drug Monitoring Revenue Forecast by Application (2021-2025)
Table 83. Global Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Therapeutic Drug Monitoring Picture
Figure 2. Global Therapeutic Drug Monitoring Revenue Market Share by Type in 2019
Figure 3. Antiepileptic Drugs Picture
Figure 4. Antiarrhythmic Drugs Picture
Figure 5. Immunosuppressant Drugs Picture
Figure 6. Antibiotic Drugs Picture
Figure 7. Bronchodilator Drugs Picture
Figure 8. Psychoactive Drugs Picture
Figure 9. Other Drug Classes Picture
Figure 10. Therapeutic Drug Monitoring Revenue Market Share by Application in 2019
Figure 11. Commercial/Private Labs Picture
Figure 12. Hospital Labs Picture
Figure 13. Others Picture
Figure 14. Global Therapeutic Drug Monitoring Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Therapeutic Drug Monitoring Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Therapeutic Drug Monitoring Revenue Market Share in 2019
Figure 23. Global Top 10 Players Therapeutic Drug Monitoring Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Therapeutic Drug Monitoring Revenue Market Share by Regions (2015-2020)
Figure 27. Global Therapeutic Drug Monitoring Revenue Market Share by Regions in 2018
Figure 28. North America Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 29. Europe Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 31. South America Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 33. North America Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Figure 34. North America Therapeutic Drug Monitoring Revenue Market Share by Countries in 2019
Figure 35. USA Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 36. Canada Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 38. Europe Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Therapeutic Drug Monitoring Revenue Market Share by Countries in 2019
Figure 40. Germany Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 41. UK Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 42. France Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 43. Russia Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 44. Italy Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Countries in 2019
Figure 47. China Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 48. Japan Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 49. Korea Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 50. India Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 52. South America Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Figure 53. South America Therapeutic Drug Monitoring Revenue Market Share by Countries in 2019
Figure 54. Brazil Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 59. UAE Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2015-2020)
Figure 62. Global Therapeutic Drug Monitoring Revenue Share by Type (2015-2020)
Figure 63. Global Therapeutic Drug Monitoring Revenue Share by Type in 2019
Figure 64. Global Therapeutic Drug Monitoring Market Share Forecast by Type (2021-2025)
Figure 65. Global Antiepileptic Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Antiarrhythmic Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Immunosuppressant Drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Antibiotic Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Bronchodilator Drugs Revenue Growth Rate (2015-2020)
Figure 70. Global Psychoactive Drugs Revenue Growth Rate (2015-2020)
Figure 71. Global Other Drug Classes Revenue Growth Rate (2015-2020)
Figure 72. Global Therapeutic Drug Monitoring Revenue Share by Application (2015-2020)
Figure 73. Global Therapeutic Drug Monitoring Revenue Share by Application in 2019
Figure 74. Global Therapeutic Drug Monitoring Market Share Forecast by Application (2021-2025)
Figure 75. Global Commercial/Private Labs Revenue Growth Rate (2015-2020)
Figure 76. Global Hospital Labs Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
Figure 82. Europe Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
Figure 84. South America Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
短腸症候群治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drugs for Short Bowel Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Shor…- 禁煙薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Smoking Cessation Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smoking Cessation Dru…
- 大うつ病性障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Major Depressive Disorder Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Major D…
- 悪性神経膠腫治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Malignant Glioma Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Malignant Glioma…
- 卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…